1,410
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Residual vital ratio predicts 5-year volume reduction and retreatment after radiofrequency ablation of benign thyroid nodules but not regrowth

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 111-113 | Received 07 Jan 2021, Accepted 11 Jan 2021, Published online: 02 Feb 2021

References

  • Yan L, Luo Y, Xie F, et al. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia. 2020;37(1):1139–1148.
  • Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the italian minimally invasive treatments of the thyroid group. Thyroid. 2020;30(12):1759–1770.
  • Sim JS, Baek JH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth. Endocrinol Metab. 2019;34(2):117–123.
  • Bernardi S, Cavallaro M, Colombin G, et al. Initial ablation ratio predicts volume reduction and retreatment after 5 years from radiofrequency ablation of benign thyroid nodules. Front Endocrinol. [ahead of print].
  • Sim JS, Baek JH. Letter to the editor regarding residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia. 2020;37(1):1310–1311.
  • Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid. 2018;28(11):1443–1449.